Asam, K., Staniszewski, A., Zhang, H., Melideo, S. L., Mazzeo, A., Voronkov, M., . . . Nicholls, R. E. (2017). Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer’s disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid. PLoS One.
Chicago Style citaatAsam, Kesava, et al. "Eicosanoyl-5-hydroxytryptamide (EHT) Prevents Alzheimer’s Disease-related Cognitive and Electrophysiological Impairments in Mice Exposed to Elevated Concentrations of Oligomeric Beta-amyloid." PLoS One 2017.
MLA citatieAsam, Kesava, et al. "Eicosanoyl-5-hydroxytryptamide (EHT) Prevents Alzheimer’s Disease-related Cognitive and Electrophysiological Impairments in Mice Exposed to Elevated Concentrations of Oligomeric Beta-amyloid." PLoS One 2017.